Dr Robert Chandler

Dr Robert Chandler is a Consultant Clinical Oncologist specialising in the management and treatment of urological malignancies, including prostate, bladder, and kidney cancers. Committed to delivering compassionate, patient-centred care, he supports individuals through every stage of their cancer journey, from initial diagnosis to treatment and ongoing management. Dr Chandler works closely with multidisciplinary teams to ensure each patient receives a comprehensive and personalised care plan tailored to their specific diagnosis and lifestyle needs.

In his clinical practice, Dr Chandler utilises a broad spectrum of advanced anti-cancer therapies. His expertise encompasses non-surgical treatments, including chemotherapy, immunotherapy, and targeted systemic anti-cancer treatments, which are designed to attack cancer cells or empower the body's immune system to fight disease. Additionally, he specialises in advanced radiotherapy techniques, such as Intensity-Modulated Radiotherapy (IMRT) and Stereotactic Ablative Radiotherapy (SABR), which precisely target tumours while minimising exposure to healthy surrounding tissue. Dr Chandler also maintains a dedicated clinical interest in cancer genomics, exploring how genetic insights can guide targeted, highly tailored treatments.

Dr Chandler holds a Master of Chemistry with Honours (MChem Hons) degree alongside his primary medical qualification (MBChB). He completed his postgraduate specialist training in London, where he gained extensive experience in managing complex oncological cases and contributed to early-phase clinical trials in advanced prostate cancer. He holds Membership of the Royal College of Physicians (MRCP) and is a Fellow of the Royal College of Radiologists (FRCR). A dedicated researcher, Dr Chandler actively serves as a Principal Investigator on national and international clinical trials aimed at improving outcomes for patients with urological cancers.